![HCV talk Biotechnology Havana 2017 Dec 6, 2017-bilde](/en/projects/_/image/30ad6d57-5857-473c-b746-fb1fb188c0e1:e32b9e46af29f022e818cee6972b30ff695dadd2/block-800-800/HCV%20talk%20Biotechnology%20Havana%202017%20Dec%206,%202017-bilde.jpg?quality=60)
SmartVac - Next Generation Viral Hepatitis B and C vaccine development in plantsand algae using advanced biotechnological tools
Hepatitis B (HBV) and C viruses (HCV) infect the human liver, triggering persistent inflammation and eventually cirrhosis and hepatocellular carcinoma (HCC), the second leading cause of cancer-related mortality worldwide. Currently, more than 500 million people are chronically infected with HBV or HCV and at high risk of developing end stage liver disease and HCC.